Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.57%
#2 Movement Movement +6.40%
#3 Palladium Network Palladium Network +5.02%
#4 Prom Prom +4.17%
#5 GRVT Token GRVT Token +3.87%
#6 Cryptopia Cryptopia +3.74%
#7 SIXSEVEN SIXSEVEN +3.67%
#8 Test Test +3.60%
#9 Kinetiq Kinetiq +3.58%
#10 Jito Jito +3.53%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Settings
Language
ENGLISH
Currency
USD
Theme
Baudax Bio, Inc. Baudax Bio, Inc.

Baudax Bio, Inc.

BXRXQ
Rank in Stocks #42133
Baudax Bio, Inc., a biotechnology company, develops and commercializes products... Baudax Bio, Inc., a biotechnology company, develops and commercializes products for hospital and other acute care related settings. The company develops T cell receptor, that focus on immune modulating therapies for orphan diseases or complications associated with such diseases, as well as the treatment of autoimmune disorders. It also develops BX1000, an intermediate-acting neuromuscular blocking agent (NMB) that is in phase II clinical trial; BX2000, an ultra- short acting NMB, which is in phase I clinical trial, as well as a proprietary blockade reversal agent; and BX3000, a NMB reversal agent that is in preclinical studies. Baudax Bio, Inc. was incorporated in 2015 and is based in Malvern, Pennsylvania. On February 22, 2024, Baudax Bio, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Eastern District of Pennsylvania.
Share Price
$0.0001
Last synced: 2026-08-11
Market Cap
$4.36K
Change (1 day)
0.00%
Change (1 year)
900.00%
Country
US
Trade Baudax Bio, Inc. (BXRXQ)

Category

Healthcare
Earnings for Baudax Bio, Inc. (BXRXQ)
Earnings in 2026 TTM: 0
According to Baudax Bio, Inc. latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Baudax Bio, Inc. from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR